This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed.
The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Delic is focused on bringing psychedelic wellness to the mainstream.
–(BUSINESS WIRE)–IRI: Prepared Foods New Products Conference. . WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Sept. 14, 2021, from 11:00 a.m.
–(BUSINESS WIRE)–The Travelers Institute , the public policy division of The Travelers Companies, Inc. Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.
hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.
There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. ” and “We only want to see data from an American source.” SB 1027 authorized the Board of Pharmacy to issue permits for marijuana cultivation and processing.
Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.
–(BUSINESS WIRE)–cbdMD, Inc. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safetydata will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS cbdMD, Inc.
Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Business highlights. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8
2] Hemp production buoyance may be attributed to strong demand, which has enabled some hemp businesses to do better in this crisis than they did before the pandemic. [3] Separately, hemp farmers are also able to obtain assistance enabled by the $2 trillion CARES Act from the Small Business Administration. CBD Enforcement Activity.
Since the passage of the Farm Bill in December of 2018 , there has been a marked uptick in interest in the cannabidiol (CBD) space from businesses and users alike. To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”.
Here’s how the 282 acres stacked up by license type: Figuring out cultivation size nationally is probably more art than science given the data gaps that exist. Currently, Oklahoma has 7,754 licenses according to the Cannabiz Media License Database – but there is no limit to how much cannabis an Oklahoma cultivator can grow.
Since the data does not support the tired narrative that legalization will inevitably lead to a spike in teenage use, opponents have pivoted to discuss increased behavioral health issues among teens based on potency. As usual, though, the evidence materially depends on personal anecdotes, scare tactics and a lack of actual scientific data.
Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Ed has managed product, marketing, and sales while overseeing complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental, and human resource markets. .
This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . triggering new innovations and improved data quality through better user experiences.
Media outlets like Marijuana Business Daily , however, obtained more information from CannTrust and offer a more complete picture. Five grow rooms may not seem too significant, but Marijuana Business Daily demonstrates that nothing could be further from the truth. Ensuring product safety and availability is our priority.”.
Colombia’s position in the industry generated enormous hype, thanks to the influx of business. South America needs safe, reliable growing materials, cannot use certain pesticides, needs to meet cleanliness and safety standards, etc. The checklist is endless, but every box needs to be marked.
I mean duh, with social media, bosses that don’t understand you have a life and the new Bob Dylan documentary on Netflix – how can anyone doze off and dream anymore? RELATED: I’m A Business Owner Who Uses Cannabis & CBD For Anxiety. Did you know sleep deficiency is a pretty common health issue in the United States?
The Department developed and received approval for eight regulatory packages that, among many things, expand support for equity applicants and licensees and lowers barriers for businesses to attain and maintain licenses. Expanded This is California Cannabis, a public awareness campaign celebrating cannabis businesses throughout the state.
These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.
The findings in this report point to policies and practices that promote and preserve public health and safety, while allowing legal businesses to compete.”. “We are pleased to release this report that highlights the successful launch of Maine’s adult use market,” said OCP Director Erik Gundersen. “The
The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In
Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.
Prioritize Safety and Privacy When ordering weed online, safety and privacy should always be a concern. Reliable companies will protect your data, such as your address and payment details, through secure systems. It’s also wise to choose a company that has been in business for a while.
Dr. Johnson recently reported his interim results at Microdose’s Psychedelic Medicine Business Event, from his current smoking cessation study, utilizing a single macro-dose of psilocybin. Preclinical data on numerous sets of Mydecine’s novel compounds are showing significant improvements compared to the first generation of drugs.
The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In
Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days.
Each of the new licensees, chosen from 10 different applicants, has previous experience in the cannabis industry either in Delaware or elsewhere according to Delaware Business Times. Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Rhode Island.
In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss license updates coming to the Cannabiz Media License Database, including Oregon cannabis licenses, Louisiana CBD licenses, and Pennsylvania, Ohio, Montana and South Carolina hemp licenses. Ed Keating : Hi Amanda.
Data To Support Regulatory Filings in the United States. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Media: Laura Radocaj. First Patient Expected to be Enrolled by Q2 of 2022. BERWYN, Pa.–(BUSINESS Altasciences helps sponsors get better drugs to the people who need them, faster.
Ability to meet the overall health needs of qualified patients and safety of the public. Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C.
Several factors are in play, according to union officials and labor experts: The pandemic increased employee anxiety and concerns about workplace health and safety, opening the window for union organizing. Unions view cannabis as a huge opportunity ,” Boston labor attorney Jonathan Keselenko recently told Marijuana Business Magazine.
In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss speak with Lews Koski, Chief Operating Officer of Metrc , a leading seed-to-sale track-and-trace technology company for the cannabis and hemp industries. Amanda Guerrero: Welcome to the Cannacurio Podcast, powered by Cannabiz Media.
Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. WRITTEN BY: Cynthia Blake Sanders. Baker Donelson.
In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss speak with Robert Mohr, Cannabis Channel Manager, and Haley Hayes, Sales Executive, from PeopleGuru , a cloud-based and cannabis-friendly HR payroll, human capital management, and technology provider. Ed Keating: I don’t know.
–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials. The results of this study underscore the safety of our spray film technology.”. Media: Laura Radocaj. BERWYN, Pa.–(BUSINESS
NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S. Media Lindsay Wilson. media@col-care.com. to bring innovation and precision to the growing UK medical cannabis market.
–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. Once the Envelta IND-enabling studies are submitted to the FDA, the data may be cross-referenced to our cancer pain and PTSD INDs.
–(BUSINESS WIRE)– #Alzheimers –India Globalization Capital, Inc. The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA. social media: www.igcinc.us / www.igcpharma.com. BETHESDA, Md.–(BUSINESS
Yet, in order to market a business’s commitment to consumer safety and environmental integrity, these values need to be communicated—but how?” “Over the years, the media has repeatedly characterized cannabis cultivation as either energy-sucking indoor grows or backwoods farms that unleash rodenticides on wildlife.
Many regulated markets mandate indoor cultivation of marijuana for “security” and “safety” reasons, but the downside is that more energy is needed to support this type of production. According to cannabis analytics firm New Frontier Data , legal and illicit cannabis crops used around 2.8 Katana Dumont.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content